Abdominal Aortic Aneurysm, Acute Myocardial Infarction, Cardiac Arrest, Cardiovascular Diseases, Cerebrovascular Accident, Chronic Stable Angina, Heart Diseases, Heart Failure, Ischemic Stroke, Peripheral Arterial Disease, Subarachnoid Hemorrhage, Sudden Coronary Death, Sudden Death, Transient Ischemic Attack, Unstable Angina, Ventricular Arrhythmia
Conditions
Keywords
Heart diseases, Cardiovascular diseases, Coronary heart disease not otherwise specified, Cerebrovascular disorders, Brain diseases, Central nervous system diseases, Nervous system diseases, Atherosclerosis, Arteriosclerosis, Pathologic processes, Acute myocardial infarction, Myocardial infarction, Myocardial ischemia, Infarction, Necrosis, Unstable angina, Chronic stable angina, Stable angina, Angina pectoris, Chest pain, Pain, Signs and symptoms, Ischemia, Ischemic stroke, Hemorrhagic stroke, Stroke, Subarachnoid hemorrhage, Transient ischemic attack, Abdominal aortic aneurysm, Aneurysm, Aortic aneurysm, Aortic aneurysm, abdominal, Aortic diseases, Peripheral arterial diseases, Peripheral vascular diseases, Vascular diseases, Peripheral occlusive diseases, Sudden coronary death, Ventricular arrhythmia, Sudden cardiac death, Cardiac arrest, Heart failure
Brief summary
Cardiovascular disease (CVD) is an important public health problem that affects millions of people worldwide. Associations between risk factors, such as smoking, dyslipidaemia or hypertension, and prevalent CVD are well documented. However, few studies have investigated associations with onset of disease. The initial manifestation of CVD, for example an episode of unstable angina, is important because it influences the prognosis, the quality of life and the management of disease. Furthermore, the extent to which social deprivation, alcohol consumption or atrial fibrillation affects presentation of CVD is poorly understood and deserves further consideration. Most previous studies have considered CVD as a single entity. However, differences in aetiology between coronary phenotypes suggest that risk factors may not be shared across specific coronary phenotypes and their relative importance is likely to differ for each phenotype. Gaining knowledge of these differences could provide insights into the pathophysiology of specific forms of CVD and could eventually lead to modification of recommendations for patient management and disease prevention. We propose to use the linkage of the national registry of coronary events to general practice records in the Clinical Practice Research Database (CPRD), to investigate whether demographic, behavioral, and clinico-metabolic risk factors differentially influence the onset of specific types of CVD.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Aged ≥30yrs old * Registered in CPRD practices in England consenting to data linkage * ≥1 year of up-to-standard pre-study follow-up
Exclusion criteria
* History of any of the CVD endpoints considered before study follow-up initiation.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| First presentation of cardiovascular disease, as specified in description | Study follow-up will commence on the earliest date on which a patient fulfils the criteria for study inclusion within the period between 1st January 1997 and 25th March 2010 (maximum of 13 years after enrolment). | First occurrence of the following fatal or non-fatal cardiovascular outcomes: acute myocardial infarction, unstable angina, stable angina, ischemic stroke, hemorrhagic stroke, subarachnoid hemorrhage, transient ischemic attack, abdominal aortic aneurysm, peripheral arterial disease, sudden cardiac death, heart failure |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Non CVD specific deaths | Same as for primary outcomes (maximum of 13 years after follow-up start) | Death from non CVD, that is, excluding deaths related to the primary endpoints. |
Other
| Measure | Time frame | Description |
|---|---|---|
| Cardiovascular heart disease and fatal cardiovascular disease | Same as for primary endpoint (maximum of 13 years after follow-up start) | Cardiovascular heart disease: combination of MI and unheralded coronary death. Cardiovascular disease: combination of fatal cardiovascular heart disease and stroke of any type. Fatal cardiovascular disease: combination of fatal coronary heart disease and fatal cardiovascular death. |